Publications for Jorma Hinkula
Co-author map based on ISI articles 2007-

Publications mentioned in social media 18 times*

Keywords

virus vaccine t systemic receptor protein presentation mucosal mice infected immunization immunity immune hiv-1 hiv dna dcs cellular cells adjuvant

Journal Articles

Toomas Timpka, Armin Spreco, Elin Gursky, Olle Eriksson, Örjan Dahlström, Magnus Strömgren, Joakim Ekberg, Sofie Pilemalm, David Karlsson, Jorma Hinkula and Einar Holm
  Intentions to perform non-pharmaceutical protective behaviors during influenza outbreaks in Sweden: a cross-sectional study following a mass vaccination campaign
  PLoS ONE, 2014, 9(3), e91060.

Sanna Nyström, Andreas Bråve, Tina Falkeborn, Claudia Devito, Björn Rissiek, Daniel X Johansson, Ulf Schröder, Satoshi Uematsu, Shizuo Akira, Jorma Hinkula and Steven E Applequist
  DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant
  Vaccines, 2013, 1(4), 415-443.
   Fulltext  PDF  

Tina Falkeborn, Andreas Brave, Marie Larsson, Britt Åkerlind, Ulf Schroder and Jorma Hinkula
  Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
  PLoS ONE, 2013, 8(8), .
   Fulltext  PDF  

Veronica Tjomsland, Rada Ellegård, Preben Kjölhede, Ninni Borendal Wodlin, Jorma Hinkula, Jeffrey Lifson and Marie Larsson
  Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions
 
Altmetric usage: 1

  European Journal of Immunology, 2013, 43(9), 2361-2372.
   Fulltext  PDF  

Veronica Tjomsland, Rada Ellegård, Adam Burgener, Kenzie Mogk, Karlhans Fru Che, Garrett Westmacott, Jorma Hinkula, Jeffrey D. Lifson and Marie Larsson
  Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells
 
Altmetric usage: 1

  European Journal of Immunology, 2013, 43(6), 1470-1483.
   Fulltext  PDF  

Edwin J. B. Veldhuis Kroeze, Koert J. Stittelaar, Vera J. Teeuwsen, Marcel L Dijkshoorn, Geert van Amerongen, Leon de Waal, Thijs Kuiken, Gabriel P. Krestin, Jorma Hinkula and Albert D. M. E Osterhaus
  Consecutive CT in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model
  Vaccine, 2012, 30(51), 7391-7394.

Karlhans Fru Che, Esaki Muthu Shankar, Sundaram Muthu, Sasan Zandi, Mikael Sigvardsson, Jorma Hinkula, Davorka Messmer and Marie Larsson
  p38 Mitogen-Activated Protein Kinase/Signal Transducer and Activator of Transcription-3 Pathway Signaling Regulates Expression of Inhibitory Molecules in T Cells Activated by HIV-1-Exposed Dendritic Cells
  Molecular medicine (Cambridge, Mass. Print), 2012, 18(8), 1169-1182.
 Web of Science® Times Cited: 5

Andreas Boberg, Alexandra Stålnacke, Andreas Bråve, Jorma Hinkula, Britta Wahren and Nils Carlin
  Receptor binding by cholera toxin B-subunit and amino acid modification improves minimal peptide immunogenecity
  ISRN Molecular Biology, 2012, 2012, .

Luigi Buonaguro, Maria Tagliamonte, Maria Luisa Visciano, Hanne Andersen, Mark Lewis, Ranajit Pal, Maria Lina Torneselloa, Ulf Schroeder, Jorma Hinkula, Britta Wahren and Franco M. Buonaguro
  Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration
 
Altmetric usage: 1

  Clinical and vaccine immunology, 2012, 19(6), 970-973.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Chien-Hsing Chang, Jorma Hinkula, Meiyu Loo, Tina Falkeborn, Rongxiu Li, Thomas M. Cardillo, Edmund A. Rossi, David M. Goldenberg and Britta Wahren
  A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro
 
Altmetric usage: 1

  PLoS ONE, 2012, 7(7), e41235-e41235.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Lech Ignatowicz, Jolanta Mazurek, Chaniya Leepiyasakulchai, Markus Sköld, Jorma Hinkula, Gunilla Källenius and Andrzej Pawlowski
  Mycobacterium tuberculosis Infection Interferes with HIV Vaccination in Mice
 
Altmetric usage: 4

  PLoS ONE, 2012, 7(7), e41205-e41205.
   Fulltext  PDF  

Lech Ignatowicz, Jolanta Mazurek, Chaniya Leepiyasakulchai, Markus Sköld, Jorma Hinkula, Gunilla Källenius and Andrzej Pawlowski
  Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.
 
Altmetric usage: 4

  PloS one, 2012, 7(7), e41205.
   Fulltext  PDF  

Susanne E Johansson, Hanna Bauner, Jorma Hinkula, Britta Wahren, Louise Berg and Maria H Johansson
  Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells
 
Altmetric usage: 2

  Cellular Immunology, 2011, 272(1), 71-78.

Susanne E Johansson, Erik Rollman, Amy W Chung, Rob J Center, Bo Hejdeman, Ivan Stratov, Jorma Hinkula, Britta Wahren, Klas Kaerre, Stephen J Kent and Louise Berg
  NK Cell Function and Antibodies Mediating ADCC in HIV-1-Infected Viremic and Controller Patients
  Viral immunology, 2011, 24(5), 359-368.
   Fulltext  PDF  
 Web of Science® Times Cited: 14

Veronica Tjomsland, Rada Ellegård, Karlhans Fru Che, Jorma Hinkula, Jeffrey D Lifson and Marie Larsson
  Complement Opsonization of HIV-1 Enhances the Uptake by Dendritic Cells and Involves the Endocytic Lectin and Integrin Receptor Families
  PLoS ONE, 2011, 6(8), .
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Vicky Jespers, Ali M Harandi, Jorma Hinkula, Donata Medaglini, Roger Le Grand, Christiane Stahl-Hennig, Willy Bogers, Raphaelle El Habib, Frank Wegmann, Carol Fraser, Martin Cranage and Robin J Shattock
  Assessment of mucosal immunity to HIV-1
  EXPERT REVIEW OF VACCINES, 2010, 9(4), 381-394.
 Web of Science® Times Cited: 12

Andreas Brave, Ulrika Johansson, David Hallengard, Shirin Heidari, Hanna Gullberg, Britta Wahren, Jorma Hinkula and Anna-Lena Spetz
  Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes
  VACCINE, 2010, 28(9), 2080-2087.
 Web of Science® Times Cited: 6

Susanne E Johansson, Bo Hejdeman, Jorma Hinkula, Maria H Johansson, Francois Romagne, Britta Wahren, Nicolai R Wagtmann, Klas Karre and Louise Berg
  NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients
 
Altmetric usage: 2

  CLINICAL IMMUNOLOGY, 2010, 134(2), 158-168.
 Web of Science® Times Cited: 7

Jorma Hinkula, Lilian Walther-Jallow, Anna Lauren, Barbro Makitalo, Monica Oberg, Britta Wahren, Eva-Maria Fenyo and Anna-Lena Spetz
  Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells
  VACCINE, 2009, 27(46), 6424-6431.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Andreas Bråve, David Hallengärd, Ulf Schröder, Pontus Blomberg, Britta Wahren and Jorma Hinkula
  Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses
  Vaccine, 2008, 26(40), 5075-5078.
 Web of Science® Times Cited: 12

Andreas Boberg, Andreas Bråve, Susanne Johansson, Britta Wahren, Jorma Hinkula and Erik Rollman
  Murine models for HIV vaccination and challenge
  Expert Review of Vaccines, 2008, 7(1), 117-130.
 Web of Science® Times Cited: 11

Claudia Istrate, Jorma Hinkula, Annie Charpilienne, Didier Poncet, Jean Cohen, Lennart Svensson and Kari Johansen
  Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice
  Vaccine, 2008, 26(35), 4594-4601.
 Web of Science® Times Cited: 10

E. Johansson, Claudia Istrate, A. Charpilienne, J. Cohen, Jorma Hinkula, D. Poncet, Lennart Svensson and K. Johansen
  Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles
  Vaccine, 2008, 26(6), 778-785.
 Web of Science® Times Cited: 11

Jorma Hinkula, Marie Hagbom, Britta Wahren and Ulf Schröder
  Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice
 
Altmetric usage: 1

  Vaccine, 2008, 26(40), 5101-5106.
 Web of Science® Times Cited: 3

Andreas Bråve, Kari Johansen, Paolo Palma, Reinhold Benthin and Jorma Hinkula
  Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant
  Vaccine, 2008, 26(47), 5957-5966.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Ingrid Lindh, Irina Kalbina, Sara Thulin, Nikolai Scherbak, Helena Savenstrand, Andreas Brave, Jorma Hinkula, Ake Strid and Soren Andersson
  Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses
  APMIS: Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum, 2008, 116(11), 985-994.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Kirsi Harila, Antti Salminen, Ian Prior, Jorma Hinkula and Maarit Suomalainen
  The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent
  Virology, 2007, 369(2), 299-308.
 Web of Science® Times Cited: 14

L Buonaguro, C Devito, ML Tornesello, U Schröder, B Wahren, Jorma Hinkula and FM Buonaguro
  DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity
 
Altmetric usage: 1

  Vaccine, 2007, 25(32), 5968-5977.
   Fulltext  PDF  
 Web of Science® Times Cited: 42

C Istrate, I Douagi, A Charpilienne, GM McInnerney, Å Hidmark, K Johansen, Marie Larsson, Karl-Eric Magnusson, D Poncet, Lennart Svensson and Jorma Hinkula
  Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus
  Scandinavian Journal of Immunology, 2007, 65(6), 494-502.
 Web of Science® Times Cited: 11

Andreas Boberg, Sabrina Dominici, Andreas Brave, Kristian Hallermalm, Jorma Hinkula, Mauro Magnani and Britta Wahren
  Immunization with HIV protease peptides linked to syngeneic erythrocytes
  Infectious Agents and Cancer, 2007, 2(1), .

Jorma Hinkula
  Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity
  Expert Review of Vaccines, 2007, 6(2), 203-212.
 Web of Science® Times Cited: 10

Erik Rollman, Nathalie Mathy, Andreas Bråve, Andreas Boberg, Anne Kjerrström, Cathy van Wely, Gunnel Engström, Susanne Johansson, Kajsa Aperia, Lars E Eriksson, Reinhold Benthin, Peter Ertl, Jonathan Heeney, Jorma Hinkula, Gerald Voss and Britta Wahren
  Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model
  Vaccine, 2007, 25(11), 2145-2154.
 Web of Science® Times Cited: 11

Daniel X Johansson, Katarina Drakenberg, Kathrin H Hopmann, Alexej Schmidt, Fayezeh Yari, Jorma Hinkula and Mats AA Persson
  Efficient expression of recombinant human monoclonal antibodies in Drosophila S2 cells
  JIM - Journal of Immunological Methods, 2007, 318( 1-2), 37-46.
 Web of Science® Times Cited: 13

Elin Kindberg, Bo Hejdeman, Göran Bratt, Britta Wahren, Bertil Lindblom, Jorma Hinkula and Lennart Svensson
  A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection
  AIDS (London), 2006, 20(5), 685-689.
 Web of Science® Times Cited: 30

Susanne Johansson, David M Goldenberg, Gary L Griffiths, Britta Wahren and Jorma Hinkula
  Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody
  AIDS (London), 2006, 20(15), 1911-1915.
 Web of Science® Times Cited: 11

Kirsi Harila, Ian Prior, Mathilda Sjöberg, Antti Salminen, Jorma Hinkula and Maarit Suomalainen
  Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag
  Journal of Virology, 2006, 80(8), 3765-3772.
 Web of Science® Times Cited: 40

Lars H Lund, Karolina Andersson, Bartek Zuber, Anneli Karlsson, Gunnel Engström, Jorma Hinkula, Britta Wahren and Gösta Winberg
  Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system
  Cancer Gene Therapy, 2003, 10, 365-376.

Conference Articles

Toomas Timpka, Elin A Gursky, Armin Spreco, Olle Eriksson, Örjan Dahlström, Magnus Strömgren, Einar Holm, Joakim Ekberg, Jorma Hinkula, Jim M Nyce and Henrik Eriksson
  Predictive value of telenursing complaints in influenza surveillance: a prospective cohort study in Sweden
  18th World Congress on Disaster and Emergency Medicine (WCDEM), 28-31 May 2013, Manchester, UK, 2013.


Toomas Timpka, Armin Spreco, Örjan Dahlström, Olle Eriksson, Elin Gursky, Joakim Ekberg, Eva Blomqvist, Magnus Strömgren, David Karlsson, Henrik Eriksson, Jim Nyce, Jorma Hinkula and Einar Holm
  Predictive value of telenursing complaints in influenza surveillance: a prospective cohort study in Sweden
  Eight Conference of Options for the Control of Influenza, Cape Town, South Africa, September 5-10, 2013, 2013.


Toomas Timpka, Armin Spreco, Örjan Dahlström, Henrik Eriksson, Elin Gursky, Joakim Ekberg, Eva Blomqvist, Magnus Strömgren, David Karlsson, Henrik Eriksson, Jim Nyce, Jorma Hinkula and Einar Holm
  Performance of eHealth data sources in local influenza surveillance: a 5-year open cohort study using data from Google Flu Trends, telenursing call centres, health service provider web-pages, and mass media coverage
  Eight Conference of Options for the Control of Influenza, Cape Town, South Africa, September 5-10, 2013, 2013.


Toomas Timpka, Armin Spreco, Örjan Dahlström, Olle Eriksson, Elin Gursky, Joakim Ekberg, Magnus Strömgren, David Karlsson, Jorma Hinkula and Einar Holm
  Intentions to perform non-pharmaceutical protective behaviors during influenza outbreaks: a cross-sectional study of a representative sample of the Swedish adult population
  Eight Conference of Options for the Control of Influenza, Cape Town, South Africa, September 5-10, 2013, 2013.


Sanna Nystrom, Andreas Brave, Bjorn Rissiek, Daniel X Johansson, Ulf Schroder, Jorma Hinkula and Steven E Applequist
  DNA-Encoded Flagellin as an Epidermal, Systemic, and Mucosal-Adjuvant in SCANDINAVIAN JOURNAL OF IMMUNOLOGY, vol 73, issue 4, pp 393-393
  SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011.


S Andersson, A Brave, I Kalbina, H Saevenstrand, Jorma Hinkula and A Strid
  Feeding of Mice with Transgenic Arabidopsis Thaliana Expressing HIV-1 Subtype C p24 gives Rise to Systemic Immune Response
  AIDS RESEARCH AND HUMAN RETROVIRUSES, ISSN 0889-2229, vol 24, 2008.


L Buonaguro, M Tornesello, Jorma Hinkula, U Schroder, B Wahren and F M Buonaguro
  Induction of Mucosal Immunity by HIV-1 VLPs Administered Intra-Nasally in Prime/Boost Protocols
  AIDS RESEARCH AND HUMAN RETROVIRUSES, ISSN 0889-2229, vol 24, 2008.


Ph.D. Theses

Veronica Tjomsland
  Complement activation - good or evil in HIV-1 infection?: interaction of free and complement opsonized HIV-1 with monocyte derived dendritic cells and immune cells in the cervical mucosa
  2011.


  Fulltext PDF

Karlhans Fru Che
  Immunomodulatory Effects of Human ImmunodeficiencyVirus (HIV-1) on Dendritic Cell and T cell Responses: Studies of HIV-1 effects on Dendritic cell functionality reflected in primed T cells
  2011.


  Fulltext PDF

Elin Kindberg
  Host genetic risk factors to viral diseases - a double-edged sword: Studies of norovirus and tick-borne encephalitis virus
  2010.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.